Dear Editor, H5N6 influenza infection is a new human disease with high death rate. This disease is a kind of atypical influenza. It was firstly reported in China in 2014 and there are three accumulated human cases at present [1] . As a new atypical influenza, the observation on atypical clinical presentation is very interesting. In general, there are many hematological problems in atypical influenza. Anemia and thrombocytopenia are common in atypical bird flu [2, 3] . Focusing on H5N6 influenza which is the newest cross species bird flu, it is questionable whether the same problem existed or not. Based on the available data on the three human H5N6 cases, there is still no evidence of anemia and thrombocytopenia. Hence, based on present data, it might be assumed that there is still no problem of anemia and thrombocytopenia in the new H5N6 influenza.
